| Mrs Marcy A Aronson, MS, CCC-SLP | |
|
106 Washington Ave, Plainview, NY 11803-4047 | |
| (516) 937-6330 | |
| Not Available |
| Full Name | Mrs Marcy A Aronson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 106 Washington Ave, Plainview, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073881140 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 007824 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Marcy A Aronson, MS, CCC-SLP 106 Washington Ave, Plainview, NY 11803-4047 Ph: (516) 937-6330 | Mrs Marcy A Aronson, MS, CCC-SLP 106 Washington Ave, Plainview, NY 11803-4047 Ph: (516) 937-6330 |
News Archive
Undernutrition is the underlying cause of more than 53 percent of all child deaths that occur annually, including those from infectious diseases, pneumonia, diarrhea, measles and malaria, according to a new analysis by researchers with the Johns Hopkins Bloomberg School of Public Health and the World Health Organization.
In this episode of the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald, vice president for communications and policy outreach at the CGD, interviews Amanda Glassman, a research fellow and director of CGD's global health program, about her recent report, Priority Setting in Health: Building Institutions for Smarter Public Spending, which "draws on the expertise of a CGD working group to offer recommendations for improving the allocation of scarce health funding, despite political and bureaucratic constraints."
Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that it has submitted a Clinical Trial Authorization application to the Medicines and Healthcare products Regulatory Agency to initiate a Phase 1/2 study of ALN-AAT02, an investigational RNAi therapeutic targeting alpha-1 antitrypsin for the treatment of AAT deficiency-associated liver disease.
The use of electroconvulsive therapy improves the chances of a treatment response in patients with continued schizophrenia symptoms despite use of antipsychotic medication, a randomised trial shows.
Octapharma USA researchers presented new stringent, objective criteria used in the evaluation of hemostatic efficacy in the treatment of von Willebrand disease and reported on their application of these criteria in clinical trials during the recently completed National Hemophilia Foundation Annual Meeting.
› Verified 8 days ago
Alison Heather Cruvant, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 113 Grace St, Plainview, NY 11803 Phone: 917-589-1884 | |
Mrs. Kylie Joy Vitale, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 255 Executive Dr Ste 108, Plainview, NY 11803 Phone: 516-576-2040 | |
Kristin Ann Collins, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 255 Executive Dr # Ll105, Plainview, NY 11803 Phone: 516-576-0962 Fax: 516-349-0961 | |
Dana P Bubolo, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 255 Executive Dr, Plainview, NY 11803 Phone: 516-576-2040 | |
Mrs. Josiane Aparecida Disaro-halilej, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 29 Gerhard Rd, Plainview, NY 11803 Phone: 526-237-2546 Fax: 516-237-2508 | |
Mrs. Ellen Kallem, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11 Saul Pl, Plainview, NY 11803 Phone: 561-681-0289 | |
Carolyn Simone, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 E Bethpage Rd, Plainview, NY 11803 Phone: 516-731-5588 |